Vincerx Pharma Valuation
| VINC Stock | USD 0.28 0.02 7.69% |
Vincerx Pharma seems to be undervalued based on Macroaxis valuation methodology. Our model measures the value of Vincerx Pharma from inspecting the company fundamentals such as Shares Owned By Institutions of 36.00 %, return on equity of -1.42, and Shares Outstanding of 30.88 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Vincerx Pharma's valuation include:
Price Book 1.0493 | Enterprise Value 1.1 M | Enterprise Value Ebitda (3.13) |
Undervalued
Today
Please note that Vincerx Pharma's price fluctuation is dangerous at this time. Calculation of the real value of Vincerx Pharma is based on 3 months time horizon. Increasing Vincerx Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Vincerx Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vincerx Stock. However, Vincerx Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.28 | Real 1.79 | Target 6.33 | Hype 0.27 | Naive 0.22 |
The real value of Vincerx Stock, also known as its intrinsic value, is the underlying worth of Vincerx Pharma Company, which is reflected in its stock price. It is based on Vincerx Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Vincerx Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Vincerx Pharma helps investors to forecast how Vincerx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vincerx Pharma more accurately as focusing exclusively on Vincerx Pharma's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Vincerx Pharma's intrinsic value based on its ongoing forecasts of Vincerx Pharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Vincerx Pharma's closest peers. If more than one evaluation category is relevant for Vincerx Pharma we suggest using both methods to arrive at a better estimate.
Vincerx Pharma Cash |
|
Vincerx Valuation Trend
Comparing Vincerx Pharma's enterprise value against its market capitalization is a good way to estimate the value of Vincerx Pharma uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Vincerx Pharma Total Value Analysis
Vincerx Pharma is at this time estimated to have valuation of 1.11 M with market capitalization of 10.48 M, debt of 2.5 M, and cash on hands of 80.86 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Vincerx Pharma fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.11 M | 10.48 M | 2.5 M | 80.86 M |
Vincerx Pharma Asset Utilization
One of the ways to look at asset utilization of Vincerx is to check how much profit was generated for every dollar of assets it reports. Vincerx Pharma has a negative utilization of assets of -0.66 %, losing $0.006599 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Vincerx Pharma shows how discouraging it operates for each dollar spent on its assets.Vincerx Pharma Ownership Allocation
Vincerx Pharma shows a total of 30.88 Million outstanding shares. 30% of Vincerx Pharma outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Vincerx Pharma Profitability Analysis
Net Loss for the year was (40.16 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Vincerx Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Vincerx Pharma and how it compares across the competition.
About Vincerx Pharma Valuation
The stock valuation mechanism determines Vincerx Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Vincerx Pharma. We calculate exposure to Vincerx Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Vincerx Pharma's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -915 K | -960.8 K |
Vincerx Pharma Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 21.3 M |
Vincerx Pharma Current Valuation Indicators
Valuation refers to the process of determining the present value of Vincerx Pharma and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Vincerx we look at many different elements of the entity such as Vincerx's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Vincerx Pharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Vincerx Pharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Vincerx Pharma's worth.Complementary Tools for Vincerx Stock analysis
When running Vincerx Pharma's price analysis, check to measure Vincerx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vincerx Pharma is operating at the current time. Most of Vincerx Pharma's value examination focuses on studying past and present price action to predict the probability of Vincerx Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vincerx Pharma's price. Additionally, you may evaluate how the addition of Vincerx Pharma to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |